JP2022507616A5 - - Google Patents

Info

Publication number
JP2022507616A5
JP2022507616A5 JP2021526737A JP2021526737A JP2022507616A5 JP 2022507616 A5 JP2022507616 A5 JP 2022507616A5 JP 2021526737 A JP2021526737 A JP 2021526737A JP 2021526737 A JP2021526737 A JP 2021526737A JP 2022507616 A5 JP2022507616 A5 JP 2022507616A5
Authority
JP
Japan
Prior art keywords
acnes
roxp
composition
strain
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021526737A
Other languages
English (en)
Japanese (ja)
Other versions
JP7532361B2 (ja
JP2022507616A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/081546 external-priority patent/WO2020099663A1/en
Publication of JP2022507616A publication Critical patent/JP2022507616A/ja
Publication of JP2022507616A5 publication Critical patent/JP2022507616A5/ja
Application granted granted Critical
Publication of JP7532361B2 publication Critical patent/JP7532361B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021526737A 2018-11-16 2019-11-15 酸化ストレスに関連付けられる皮膚疾患及び皮膚老化を処置するための組成物ならびに酸化ストレスに関連付けられる皮膚疾患の診断。 Active JP7532361B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18206646.4 2018-11-16
EP18206646 2018-11-16
PCT/EP2019/081546 WO2020099663A1 (en) 2018-11-16 2019-11-15 Compositions for treating oxidative stress-associated skin diseases and skin ageing and diagnosis of oxidative stress-associated skin diseases

Publications (3)

Publication Number Publication Date
JP2022507616A JP2022507616A (ja) 2022-01-18
JP2022507616A5 true JP2022507616A5 (https=) 2022-11-16
JP7532361B2 JP7532361B2 (ja) 2024-08-13

Family

ID=64331864

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021526737A Active JP7532361B2 (ja) 2018-11-16 2019-11-15 酸化ストレスに関連付けられる皮膚疾患及び皮膚老化を処置するための組成物ならびに酸化ストレスに関連付けられる皮膚疾患の診断。

Country Status (12)

Country Link
US (1) US20220000762A1 (https=)
EP (1) EP3880304B8 (https=)
JP (1) JP7532361B2 (https=)
KR (1) KR102913696B1 (https=)
CN (1) CN113038959B (https=)
AU (1) AU2019380669B2 (https=)
BR (1) BR112021008496A2 (https=)
CA (1) CA3118524A1 (https=)
ES (1) ES2994459T3 (https=)
MX (1) MX2021005755A (https=)
PL (1) PL3880304T3 (https=)
WO (1) WO2020099663A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3158054T1 (sl) 2014-06-17 2025-06-30 Crown Laboratories, Inc. Genetsko modificirane bakterije in postopki za genetsko modifikacijo bakterij
EP3285872A4 (en) 2015-04-20 2019-02-20 S-Biomedic NV METHOD AND COMPOSITIONS FOR CHANGING THE COMPOSITION OF SKIN MICROBIOMA WITH COMPLEX MIXTURES OF BACTERIAL BARS
WO2017147507A1 (en) 2016-02-24 2017-08-31 Xycrobe Therapeutics, Inc. Skin probiotic formulation
US11541081B2 (en) 2016-10-19 2023-01-03 S-Biomedic Nv Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains
US12102710B2 (en) 2020-06-23 2024-10-01 Crown Laboratories, Inc. Probiotic skin formulations
CN116940330A (zh) * 2020-12-21 2023-10-24 南洋理工大学 短链脂肪酸作为去屑剂的用途
CN113219097B (zh) * 2021-01-15 2022-06-24 杭州海关技术中心 婴幼儿配方奶粉中肉碱对映体拆分和测定方法
EP4197523A1 (en) * 2021-12-17 2023-06-21 DSM IP Assets B.V. A freeze-dried composition and preparation thereof
WO2023110886A1 (en) * 2021-12-17 2023-06-22 S-Biomedic A freeze-dried composition and preparation thereof
MX2024008578A (es) * 2022-01-12 2024-07-23 S Biomedic Nv Composicion para el cuidado de la piel y usos de la misma.
CN115165819B (zh) * 2022-05-27 2024-08-09 天津科技大学 一种快速定量分析芦丁的荧光分子印迹光子晶体凝胶条的制备方法及应用
CN120173837B (zh) * 2025-05-21 2025-12-05 杭州微致生物科技有限公司 痤疮丙酸杆菌vb208基因编辑方法及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
JP2011037764A (ja) * 2009-08-11 2011-02-24 Shiseido Co Ltd 皮膚外用剤、美白剤、抗酸化剤および抗老化剤
FR2954140A1 (fr) * 2009-12-17 2011-06-24 Oreal Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques
ITPR20110035A1 (it) 2011-05-06 2012-11-07 Bormioli Rocco & Figlio Spa Capsula.
EP2825676B1 (en) * 2012-03-17 2017-12-20 The Regents of The University of California Fast diagnosis and personalized treatments for acne
ITUA20162141A1 (it) 2016-03-31 2017-10-01 Bormioli Pharma Spa Capsula di chiusura
IT201600097495A1 (it) 2016-09-28 2018-03-28 Bormioli Pharma S R L Capsula con struttura di contenimento e rilascio di un prodotto
US11541081B2 (en) 2016-10-19 2023-01-03 S-Biomedic Nv Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains

Similar Documents

Publication Publication Date Title
JP2022507616A5 (https=)
Xie et al. Neuroprotective effect of ginsenoside-Rg1 on cerebral ischemia/reperfusion injury in rats by downregulating protease-activated receptor-1 expression
BR112021008496A2 (pt) composições para o tratamento de doenças de pele associadas a estresse oxidativo e envelhecimento da pele e diagnóstico de doenças de pele associadas a estresse oxidativo
Xiao et al. Edaravone dexborneol protects against cerebral ischemia/reperfusion-induced blood-brain barrier damage by inhibiting ferroptosis via activation of nrf-2/HO-1/GPX4 signaling
Sintov et al. Inhibition of cancer growth and induction of apoptosis by BGP-13 and BGP-15, new calcipotriene-derived vitamin D3 analogs, in-vitro and in-vivo studies
JP7604020B2 (ja) 環状ペプチド並びに該環状ペプチドを含む医薬品、外用剤および化粧料
JP2022501330A5 (https=)
Mittal et al. Molecular mechanisms and epigenetic regulation in diabetic cardiomyopathy
JP2015523553A5 (https=)
JP2015521632A5 (https=)
KR20230135586A (ko) Atp 합성효소 억제제 - 미용 및 치료 용도
KR20190060492A (ko) 그래핀 양자점을 포함하는 항염증용 조성물
CA2857250A1 (en) Compositions for preventing or treating adverse reactions of egfr inhibition
Wang et al. Local multiple-site injections of a plasmid encoding human MnSOD mitigate radiation-induced skin injury by inhibiting ferroptosis
WO2014054841A1 (ko) Abh 항원의 발현을 조절하는 물질을 포함하는 조성물
KR102152637B1 (ko) 케모카인을 함유하는 피부 미백용 조성물
Wang et al. Gamma-aminobutyric acid enhances miR-21-5p loading into adipose-derived stem cell extracellular vesicles to alleviate myocardial ischemia-reperfusion injury via TXNIP regulation
CN107072979B (zh) 类黄酮化合物在制备伤口愈合组合物的用途
KR102137581B1 (ko) 고장초 추출물을 유효성분으로 함유하는 항균용 조성물
CN112007039B (zh) 一种包含氟西汀和维生素d3或其衍生物的组合物,及其应用
EP3164110B1 (en) Pharmaceutical compositions for the treatment of psoriasis
Masaaki et al. Infantile acropustulosis treated successfully with topical maxacalcitol
EP3925605B1 (en) Method for preventing and/or treating a stress-induced disease
CN119746028B (zh) 一种多肽在治疗银屑病中的应用
CN107519482B (zh) 一种白介素28a作为制备治疗银屑病药物中的应用